Alcala, Jianah Jane R.

HRN: 22-51-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2023
AMPICILLIN 1GM (VIAL)
08/10/2023
08/16/2023
IV
175mg
Q6
Pcap
Waiting Final Action 
08/10/2023
AMPICILLIN 250MG (VIAL)
08/10/2023
08/16/2023
IV
175
Q6
Pcapc
Waiting Final Action 
08/11/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
08/11/2023
08/18/2023
PO
2.5ml
Tid
AGE
Waiting Final Action 
08/11/2023
CEFTRIAXONE 1G (VIAL)
08/11/2023
08/18/2023
IV
700mg
Q24
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: